Solid Biosciences (SLDB) Return on Capital Employed (QoQ) (2018 - 2026)

Solid Biosciences (SLDB) Return on Capital Employed (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Solid Biosciences 529.40 Mn 529.40 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,550.00
Dec 31, 2025 -1,494.00
Sep 30, 2025 -1,368.00
Jun 30, 2025 724.00
Mar 31, 2025 1,614.00
Dec 31, 2024 -1,986.00
Sep 30, 2024 -1,203.00
Jun 30, 2024 705.00
Mar 31, 2024 1,355.00
Dec 31, 2023 12.00
Sep 30, 2023 -823.00
Jun 30, 2023 -656.00
Mar 31, 2023 291.00
Dec 31, 2022 -284.00
Sep 30, 2022 -349.00
Jun 30, 2022 -620.00
Mar 31, 2022 -745.00
Dec 31, 2021 -137.00
Sep 30, 2021 -103.00
Jun 30, 2021 730.00